Not exact matches
With the results of the current
study in hand, Snyder has brokered a deal between that company and the National Institute on Drug Abuse (NIDA) for NIDA to test CGP3466B as a
treatment for
cocaine addiction.
Host: Dr. Shernaz Bamji Speaker: Dr. Antonello Bonci, NIH / NIDA Title: Synaptic and optogenetic
studies in the limbic system: implications for a novel
treatment against
cocaine abuse
Node Smith, ND A very interesting
study on an off - label use of a common diabetes medication for the
treatment of
cocaine addiction was recently published in the journal Neuropsychopharmacology.1 The research is specifically addressing the tendency for
cocaine addicts to relapse on the drug.
Increasing
treatment compliance among outpatients with comorbid depression and
cocaine dependence: results of a pilot
study